Systems biology strategy reveals PKCδ is key for sensitizing TRAIL- resistant human fibrosarcoma" in Frontiers in Immunology

A group of IAB researchers including Dr. Kumar Selvarajoo published the findings of a new study entitled "Systems biology strategy reveals PKCδ is key for sensitizing TRAIL-resistant human fibrosarcoma" in Frontiers in Immunology on January 5, 2015.(http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00659/abstract)